- Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
- Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
- Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
- Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
- Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
- Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
- Cognition Therapeutics Announces Proposed Public Offering of Common Stock
- Cognition Therapeutics to Present at the TD Cowen Health Care Conference
- Cognition Therapeutics CEO Issues Letter to Shareholders
- Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
More ▼
Key statistics
On Tuesday, Cognition Therapeutics Inc (CGTX:NMQ) closed at 1.79, 98.87% above the 52 week low of 0.9001 set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.90 |
---|---|
High | 1.90 |
Low | 1.71 |
Bid | 1.80 |
Offer | 1.82 |
Previous close | 1.88 |
Average volume | 140.48k |
---|---|
Shares outstanding | 40.06m |
Free float | 38.41m |
P/E (TTM) | -- |
Market cap | 75.31m USD |
EPS (TTM) | -0.9155 USD |
Data delayed at least 15 minutes, as of Jul 23 2024 21:00 BST.
More ▼